Skip to page content

Preventive Health Care

Blog
As the Vaccines Arrive, So Do the Questions
As the first COVID-19 vaccines are being administered across the United States, countless questions have arisen about what comes next. Is one vaccine better than another? Can the United States both speed up inoculation and overcome some people's hesitance to get the shot? RAND experts offer insights into the historic vaccine rollout.
Jan 11, 2021
Multimedia
Overcoming Hurdles to Herd Immunity
RAND senior physician policy researcher Mahshid Abir describes several hurdles to achieving herd immunity to COVID-19, including the politicization of the vaccine and the spread of misinformation.
Jan 8, 2021
Periodical
RAND Review: January-February 2021
The cover story on the ’Internet of Bodies’ highlights the perils of devices that track personal health data and provide medical treatment. Other columns explore vaccine hesitancy, the high price of insulin in the U.S., and social justice in America.
Jan 6, 2021
Journal Article
Treatment of Opioid Use Disorder During COVID-19: Experiences of Clinicians Transitioning to Telemedicine
In the context of the pandemic, buprenorphine prescribers quickly transitioned to providing telemedicine visits in high volume; nonetheless, there are still many unknowns, including the quality and safety of widespread use of telemedicine for OUD treatment.
Jan 6, 2021
Commentary
Vaccine Nationalism Has Real Economic Consequences
Vaccine nationalism, in which countries prioritize their domestic needs at the expense of others, will have significant global economic consequences. Major economies actually have more to gain by helping to make an effective COVID-19 vaccine widely available globally.
Dec 30, 2020
Journal Article
Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic
Retail buprenorphine sales for opioid addiction plateau during COVID-19 pandemic amidst sharp declines in total prescription sales.
Dec 30, 2020
Q&A
Medical Mistrust Could Reduce Vaccine Uptake: Q&A with Laura Bogart
Laura Bogart, a senior behavioral scientist, studies how discrimination feeds medical mistrust and conspiracy beliefs. Her research on how mistrust became a barrier to treatment for Black Americans during the HIV epidemic sheds light on why some might question the safety of a COVID-19 vaccine.
Dec 23, 2020
Commentary
A Case for Vaccinating Teachers First
Most agree that America's 18 million health care workers should top the list for COVID-19 vaccination. The 3.3 million teachers should come next. Vaccinating teachers could make it possible to open schools permanently and get parents back to work. That would help the economy recover.
Dec 19, 2020
Commentary
The Compensation System for Potential Side Effects Is an Important Part of a COVID-19 Vaccine Campaign
Concern about potential COVID-19 vaccine side effects and their consequences may be contributing to Americans' reluctance to get vaccinated. Policymakers and the public should carefully consider what types and levels of compensation for any adverse effects of vaccination are truly fair and appropriate.
Dec 18, 2020
Blog
Americans' Financial Struggles, COVID-19 Vaccinations, Virtual Schools: RAND Weekly Recap
This weekly recap focuses on Americans' ongoing financial struggles, how we can learn from the first phase of COVID-19 vaccinations, why virtual schools may be here to stay, and more.
Dec 18, 2020
Research Brief
The economic benefits of equitable global access to COVID-19 vaccines
Researchers used a global macroeconomic model to examine the economic effects of vaccine nationalism. This brief highlights the cost to 30 high-income countries if low and middle-income countries miss out on initial access to COVID-19 vaccines.
Dec 17, 2020
Commentary
COVID-19 Vaccination: Expect the Unexpected
With emergency use authorization for the first COVID-19 vaccine now in place, states and localities have turned their focus to the logistics of dispensing it as quickly as feasible. Still, uncertainties abound. It is essential to build a process of learning into the plan.
Dec 15, 2020
Blog
Civic Education, 'Vaccine Nationalism,' Polar Icebreakers: RAND Weekly Recap
This weekly recap focuses on how to revive civic education in America's public schools, the costs of
Dec 11, 2020
Blog
Restoring Public Trust, COVID-19 and Thanksgiving, Vaccinating Teachers: RAND Weekly Recap
This weekly recap focuses on how the Biden-Harris administration can restore public trust, the risk of Thanksgiving becoming a super-spreader event, why teachers should be among the first to get a COVID19 vaccination, and more.
Nov 26, 2020
Research Brief
Unequal Access to COVID-19 Vaccines Would Further Damage the Global Economy
As long as the coronavirus is not under control in all regions of the world there will continue to be a global economic cost associated with COVID-19. Vaccine nationalism could cost up to $1.2 trillion a year in GDP. If the poorest countries cannot access vaccines, the loss would be between $60 and $340 billion a year.
Nov 5, 2020
Essay
There's Help for Veterans with Mental Health and Substance Use Disorders
Many post-9/11 veterans who have PTSD or depression also struggle with substance use. There are clinically proven treatments to help break the cycle of the co-occurring disorders, but the VA and other facilities need guidance on how to expand and enhance treatment opportunities for these veterans.
Nov 4, 2020
Journal Article
Telehealth Capability in the U.S. at the Onset of COVID-19
Relatively few substance use treatment facilities in the United States offered telehealth services at the onset of the COVID-19 pandemic.
Nov 3, 2020
Blog
'Vaccine Nationalism,' a Pandemic Election, Women in the Workforce: RAND Weekly Recap
This weekly recap focuses on why 'vaccine nationalism' could be costly, how Americans feel about voting during a pandemic, why women are leaving the workforce, and more.
Oct 30, 2020
Report
COVID-19 'Vaccine Nationalism' Could Cost $1.2 Trillion a Year
Nationalistic behavior by governments may exclude some countries from access to COVID-19 vaccines. This could cost the world economy up to $1.2 trillion a year in GDP. A globally coordinated effort to fight the pandemic is key, not only from a public health perspective but also an economic one.
Oct 28, 2020
Multimedia
RAND Remote Series: Tackling an Evolving Pandemic
In this video conversation, Jennifer Bouey discusses RAND's rapid COVID-19 response, including insights and analysis to help strengthen and safeguard communities, rethink and retool institutions, and determine the best ways forward.
Oct 22, 2020

Previous
5
6
7
8
9
10
11
12
13
14
Next

Research conducted by

RAND Health Care

Researcher Spotlight

Laura J. Faherty

Physician Policy Researcher

Laura Faherty (she/her) is a physician policy researcher at the RAND Corporation, professor of policy analysis at the Pardee RAND Graduate School, and attending physician at Maine Medical Center. Prior to joining RAND, she was a Robert Wood Johnson Clinical Scholar at the University of…
Stephanie Stockwell

Analyst

Stephanie Stockwell (she/her) is an analyst at RAND Europe focusing on health and wellbeing. Her research interests include lifestyle behaviours such as physical activity and sedentary behaviour, health over the life course with particular interest in child and older adult populations, disease…

Explore Our People »